Registry for Study of Coils in Intracranial Aneurysms
Completed
Conditions studied: Cerebral Aneurysms
In brief
The current proposal describes a post-market, clinical registry of HydroSoft, aimed at gaining robust clinical data in a large set of patients to better define the advantages, and potentially, the disadvantages of the HydroSoft, and to inform future randomized trials.
Key facts
- Study ID
- NCT01000675
- Run by
- Mayo Clinic
- People needed
- 114
- Starts
- 2009-08-01
- Expected to finish
- 2016-12-01
- Last updated by the study team
- 2019-06-06
Who can join
Age: 21 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient presenting with a ruptured or un-ruptured cerebral aneurysm appropriate for endovascular treatment as determined by the neurovascular team (neurosurgeon/neurointerventionist)
- Patient age: patients aged between 21 and 90 years will be eligible.
- Patient HUNT AND HESS Grade 0-3.
- Patient has given fully informed consent to endovascular coiling procedure or if patient cannot consent for themselves, appropriate written consent has been sought from their next of kin, or from appropriate power of attorney.
- Aneurysm 3-15mm in maximum diameter.
- Patient is willing and able to return for follow up angiography or MRA between 6-18 months.
- The patient has not been previously entered into this registry
- The aneurysm has not previously been treated (by coiling or clipping).
You may not qualify if…
- Inability to obtain informed consent.
- Medical or surgical comorbidity such that the patient's life expectancy is less than 1 year.
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.